ERBB2 and breast cancer: Considering the limitations in our study, we have the following considerations: (1) We expect that multi-center and large sample size studies could continue to explore the risk factors of BM and prognosis in HER2-positive BC in the future, so that we could establish a prediction model to predict the likelihood of BM in HER2-positive BC.